Stock markets in Europe, plus US index futures are flat this morning while currencies are steady. Commodities have been active, along with resource stocks.
 
Overnight, both China and Germany reported growing and higher than expected trade surpluses, which could attract political attention. The market, however has focused on the fact that for China, both imports and exports grew significantly less than expected, raising questions that perhaps China isn’t doing as well as traders had been thinking. This news sent Australian stocks down 0.5% and copper down 0.3%.
 
This action suggests that Canadian resou‎rce stocks could come under pressure today although a 0.5% bounce from WTI crude oil could cushion the blow. Crude oil may remain active around the OPEC Non-OPEC meeting on compliance with production targets and tonight's Weekly API inventories.
 
US indices continue to have a mixed performance, with the Dow holding 22,000 while the SPX and NDAQ still refuse to confirm the breakout. There are a ton of earnings due from smaller companies which could influence breadth and broad market sentiment. In Canada, Valeant Pharmaceuticals could be active after beating the street on earnings but trimming sales guidance. 
 
 
Corporate News
 
Valeant Pharmaadjusted EBITDA $951M vs street $895M, sales $2.2B as expected, maintains full year adjusted EBITDA guidance $3.6-3.75B above street $3.5B, cuts sales guidance to $8.7-8.9B from $8.9-9.1B 
 
Hydro One$0.20 vs street $0.24
 
Economic News
 
Significant announcements released overnight include:
 
China trade balance$46.7B vs street $45.0B
China exports7.2% vs street 11.0%
China imports11.0% vs street 19.8%
 
Germany trade balance€22.3B vs previous €22.0B and street €23.0B
 
 
Upcoming significant economic announcements include:
 
approx 4:30 pm EDTUS API crude oil inventories
 
 
CMC Markets is an execution only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.